Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
IMRX compared with AGMB: revenue, margins and what each company keeps, and the suppliers and customers both name
IMRX
Immuneering Corp
Change
Mkt cap
Revenue
Revenue
AGMB
Agomab Therapeutics NV
Change
Mkt cap
Revenue
Revenue
vs
Compare
IMRX
Immuneering Corp
vs
AGMB
Agomab Therapeutics NV
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
IMRX
2 of 4 reports
0 of 2
at or beyond implied
Report
implied
realized
× implied
Oct 30 '26
±23.8%
▼
−6.84%
×0.29
Q2 FY26
±18.2%
▼
−0.23%
×0.01
AGMB
No earnings history for AGMB.
= implied
IMRX realized, solid
AGMB realized, hatched
One scale, both sides: full bar = 24%
× = |realized| ÷ implied
Source: market data
IMRX
Immuneering Corp
Change
3.54
▲
+5.10%
Mkt cap
$218.0M
AGMB
Agomab Therapeutics NV
Change
8.05
▲
+15.49%
Regular session
Nov 6 '26
Mkt cap
$234.0M
vs
Compare
Regular session
Nov 6 '26
IMRX
Immuneering Corp
vs
AGMB
Agomab Therapeutics NV
3.54
▲
+5.10%
Price
8.05
▲
+15.49%
$218.0M
Mkt cap
$234.0M
Change
Change
IMRX
3.54
▲
+5.10%
vs
AGMB
8.05
▲
+15.49%
Regular session
Nov 6 '26